AUTL
Autolus Therapeutics plcstockNASDAQADR
At CloseNov 3, 2026 3:59:55 PM EST
1.41USD-0.352%(-0.01)2,888,554
Pre-marketNov 3, 2026 9:29:59 AM EST
1.43USD+1.056%(+0.01)
After-hoursNov 3, 2026 4:55:30 PM EST
1.4231USD+0.572%(+0.0081)
AUTL Financials
In Q2 FY 2026 (ended ), Autolus Therapeutics plc (AUTL) reported revenue of $45.69M, net income of −$39.11M, operating cash flow of −$25.07M, and assets of $493.23M.
Loading financial statements…